- Home
- SNTI vs CNVS Comparison
SNTI vs CNVS Comparison
Compare SNTI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- CNVS
- Stock Information
- Founded
- SNTI 2016
- CNVS 2000
- Country
- SNTI United States
- CNVS United States
- Employees
- SNTI 48
- CNVS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- CNVS Consumer Electronics/Video Chains
- Sector
- SNTI Health Care
- CNVS Consumer Discretionary
- Exchange
- SNTI Nasdaq
- CNVS Nasdaq
- Market Cap
- SNTI 18.2M
- CNVS 57.8M
- IPO Year
- SNTI N/A
- CNVS 2003
- Fundamental
- Price
- SNTI $3.97
- CNVS $3.52
- Analyst Decision
- SNTI Strong Buy
- CNVS Buy
- Analyst Count
- SNTI 1
- CNVS 1
- Target Price
- SNTI $12.00
- CNVS $10.00
- AVG Volume (30 Days)
- SNTI 7.2M
- CNVS 206.9K
- Earning Date
- SNTI 11-14-2024
- CNVS 02-12-2025
- Dividend Yield
- SNTI N/A
- CNVS N/A
- EPS Growth
- SNTI N/A
- CNVS N/A
- EPS
- SNTI N/A
- CNVS N/A
- Revenue
- SNTI N/A
- CNVS $45,005,000.00
- Revenue This Year
- SNTI $254.47
- CNVS $50.96
- Revenue Next Year
- SNTI $169.66
- CNVS N/A
- P/E Ratio
- SNTI N/A
- CNVS N/A
- Revenue Growth
- SNTI N/A
- CNVS N/A
- 52 Week Low
- SNTI $1.52
- CNVS $0.72
- 52 Week High
- SNTI $16.94
- CNVS $4.19
- Technical
- Relative Strength Index (RSI)
- SNTI 47.37
- CNVS 53.07
- Support Level
- SNTI $3.60
- CNVS $3.29
- Resistance Level
- SNTI $5.96
- CNVS $3.56
- Average True Range (ATR)
- SNTI 1.02
- CNVS 0.29
- MACD
- SNTI -0.29
- CNVS -0.09
- Stochastic Oscillator
- SNTI 5.74
- CNVS 40.90
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).